Nuclin Chemicals India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 26-12-2024
- Paid Up Capital ₹ 0.20 M
as on 26-12-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 7174.50%
(FY 2020)
- Profit 90.84%
(FY 2020)
- Ebitda -172.04%
(FY 2020)
- Net Worth -15.05%
(FY 2020)
- Total Assets 615.10%
(FY 2020)
About Nuclin Chemicals India
The Corporate was formerly known as Rdx Chemicals India Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Sharma and Mohit Kaushik serve as directors at the Company.
- CIN/LLPIN
U24240UP2016PTC086312
- Company No.
086312
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2016
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Nuclin Chemicals India Private Limited offer?
Nuclin Chemicals India Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Water Treatment Chemicals, Cleaning Liquids & Wipes, Cleaning Chemicals, Hand Sanitizers & Personal Hygiene, Hand Wash, Scale Inhibitor, Boiler Chemicals, Plastic & Glass Labware, Laboratory Bottles.
Who are the key members and board of directors at Nuclin Chemicals India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Sharma  | Director | 12-Sep-2016 | Current |
| Mohit Kaushik | Director | 01-Jun-2019 | Current |
Financial Performance of Nuclin Chemicals India.
Nuclin Chemicals India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 7174.5% increase. The company also saw a substantial improvement in profitability, with a 90.84% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nuclin Chemicals India?
In 2017, Nuclin Chemicals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nuclin Chemicals India?
Unlock and access historical data on people associated with Nuclin Chemicals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuclin Chemicals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuclin Chemicals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
